These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25981576)

  • 21. Transvenous and subcutaneous implantable cardioverter defibrillators: radiographic assessment.
    Daly BD; Cascade PN; Hummel JD; Kalbfleisch S; Strickberger SA; Langberg J; Morady F
    Radiology; 1994 Apr; 191(1):273-8. PubMed ID: 8134587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous implantable cardioverter-defibrillator lead erosion after weight loss.
    Pai RK; Cadman CS
    Cardiol Rev; 2005; 13(1):27. PubMed ID: 15596025
    [No Abstract]   [Full Text] [Related]  

  • 23. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.
    Borleffs CJ; Thijssen J; de Bie MK; van Rees JB; van Welsenes GH; van Erven L; Bax JJ; Cannegieter SC; Schalij MJ
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):1013-9. PubMed ID: 20456647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual case of impossible communication between an ICD and programmer.
    Attanasio P; Wutzler A; Huemer M; Parwani AS; Boldt LH; Haverkamp W; Blaschke F
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):230. PubMed ID: 25257919
    [No Abstract]   [Full Text] [Related]  

  • 28. Labelled leucocyte scintigraphy in an infected externalized Riata lead.
    Golzio PG; Manganiello S; Gaita F
    Europace; 2014 Oct; 16(10):1442. PubMed ID: 25145339
    [No Abstract]   [Full Text] [Related]  

  • 29. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks.
    Tzeis S; Andrikopoulos G; Kolb C; Vardas PE
    Europace; 2008 Nov; 10(11):1256-65. PubMed ID: 18708639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The complications of implantable cardioverter-defibrillators and their treatment].
    Iorio D; Bonifazi R; Aquino TM; Santise G; Spampinato N
    G Chir; 1999 May; 20(5):238-40. PubMed ID: 10380366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchopericardial fistula after placement of an automatic implantable cardioverter defibrillator: radiographic and CT findings.
    Nolan RL; McAdams HP
    AJR Am J Roentgenol; 1999 Feb; 172(2):365-8. PubMed ID: 9930783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erosion of an implantable cardioverter-defibrillator.
    Elmouchi D; Woelfel A
    J Am Coll Cardiol; 2012 Jun; 59(24):e47. PubMed ID: 22676947
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardioverter defibrillator infections and community-associated MRSA: diseases of progress.
    Bishara J
    Isr Med Assoc J; 2012 Dec; 14(12):760-2. PubMed ID: 23393715
    [No Abstract]   [Full Text] [Related]  

  • 34. A subcutaneous finger cardioverter-defibrillator system removal under local anesthesia.
    Calvagna GM; Patanè S
    Int J Cardiol; 2015 Jan; 179():42-5. PubMed ID: 25464407
    [No Abstract]   [Full Text] [Related]  

  • 35. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
    Moore DR; Kok LC; Vijayaraman P
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
    [No Abstract]   [Full Text] [Related]  

  • 36. Inappropriate shocks of implantable cardioverter-defibrillator during central venous access: A preventable complication.
    Veloso HH; Chaves JC; Sobrinho JJ
    Int J Cardiol; 2016 Feb; 204():61-3. PubMed ID: 26655541
    [No Abstract]   [Full Text] [Related]  

  • 37. Pacing-dependency following implantable cardioverter-defibrillator shocks: a case report.
    Webber MR; Levings SL; Stiles MK
    J Electrocardiol; 2013; 46(2):142-4. PubMed ID: 23177276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrical storm in implantable cardioverter defibrillator recipients.
    Hannibal GB
    AACN Adv Crit Care; 2012; 23(1):108-12. PubMed ID: 22290097
    [No Abstract]   [Full Text] [Related]  

  • 39. Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator.
    Kolb C; Zrenner B; Schmitt C
    Int J Cardiol; 2006 Oct; 112(3):e74-5. PubMed ID: 16859778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Care of the pacemaker/implantable cardioverter defibrillator patient in the ED.
    McMullan J; Valento M; Attari M; Venkat A
    Am J Emerg Med; 2007 Sep; 25(7):812-22. PubMed ID: 17870488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.